BiVictriX Therapeutics.
19 announcements.
19 announcements.
| Time | Date | Ticker | Company | Announcement |
|---|---|---|---|---|
| 07:00 | 28-03-2024 | BVX | BiVictriX Therapeutics | Grant of Options – PDMR/Director Dealings |
| 12:30 | 04-01-2024 | BVX | BiVictriX Therapeutics | Holding(s) in Company |
| 12:30 | 04-01-2024 | BVX | BiVictriX Therapeutics | Holding(s) in Company |
| 07:00 | 04-01-2024 | BVX | BiVictriX Therapeutics | BiVictriX Hosts Inaugural Roundtable Discussion |
| 11:08 | 05-12-2023 | BVX | BiVictriX Therapeutics | Board Change |
| 07:00 | 30-11-2023 | BVX | BiVictriX Therapeutics | Pipeline update on BVX002 |
| 17:14 | 22-11-2023 | BVX | BiVictriX Therapeutics | Holding(s) in Company |
| 07:00 | 15-11-2023 | BVX | BiVictriX Therapeutics | Patent Granted in Japan |
| 07:00 | 12-10-2023 | BVX | BiVictriX Therapeutics | Extended Survival Rates Reported with BVX001 |
| 07:00 | 03-10-2023 | BVX | BiVictriX Therapeutics | Appointment of Adrian Howd as CFO and CBO |
| 07:00 | 19-09-2023 | BVX | BiVictriX Therapeutics | Interim Results |
| 07:00 | 31-08-2023 | BVX | BiVictriX Therapeutics | Total Voting Rights |
| 07:00 | 17-08-2023 | BVX | BiVictriX Therapeutics | Holding(s) in Company |
| 16:17 | 11-08-2023 | BVX | BiVictriX Therapeutics | Holding(s) in Company |
| 17:18 | 08-08-2023 | BVX | BiVictriX Therapeutics | Result of General Meeting |
| 12:31 | 19-07-2023 | BVX | BiVictriX Therapeutics | Proposed Fundraise in excess of £2 million |
| 07:00 | 17-07-2023 | BVX | BiVictriX Therapeutics | Positive final data in preclinical efficacy study |
| 07:00 | 19-06-2023 | BVX | BiVictriX Therapeutics | Positive interim data |
| 07:00 | 06-06-2023 | BVX | BiVictriX Therapeutics | BiVictriX nominates clinical candidate for BVX001 |